223 related articles for article (PubMed ID: 10666684)
1. The "gene dosage effect" hypothesis versus the "amplified developmental instability" hypothesis in Down syndrome.
Pritchard MA; Kola I
J Neural Transm Suppl; 1999; 57():293-303. PubMed ID: 10666684
[TBL] [Abstract][Full Text] [Related]
2. Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms.
Rachidi M; Lopes C
Neurosci Res; 2007 Dec; 59(4):349-69. PubMed ID: 17897742
[TBL] [Abstract][Full Text] [Related]
3. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part I).
Cheon MS; Kim SH; Yaspo ML; Blasi F; Aoki Y; Melen K; Lubec G
Amino Acids; 2003; 24(1-2):111-7. PubMed ID: 12624742
[TBL] [Abstract][Full Text] [Related]
4. Down syndrome--a gene dosage disease caused by trisomy of genes within a small segment of the long arm of chromosome 21, exemplified by the study of effects from the superoxide-dismutase type 1 (SOD-1) gene.
Annerén G; Edman B
APMIS Suppl; 1993; 40():71-9. PubMed ID: 8311993
[TBL] [Abstract][Full Text] [Related]
5. Evidence against the current hypothesis of "gene dosage effects" of trisomy 21: ets-2, encoded on chromosome 21" is not overexpressed in hearts of patients with Down Syndrome.
Greber-Platzer S; Schatzmann-Turhani D; Wollenek G; Lubec G
Biochem Biophys Res Commun; 1999 Jan; 254(2):395-9. PubMed ID: 9918849
[TBL] [Abstract][Full Text] [Related]
6. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome.
Amano K; Sago H; Uchikawa C; Suzuki T; Kotliarova SE; Nukina N; Epstein CJ; Yamakawa K
Hum Mol Genet; 2004 Jul; 13(13):1333-40. PubMed ID: 15138197
[TBL] [Abstract][Full Text] [Related]
7. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part III).
Cheon MS; Kim SH; Ovod V; Kopitar Jerala N; Morgan JI; Hatefi Y; Ijuin T; Takenawa T; Lubec G
Amino Acids; 2003; 24(1-2):127-34. PubMed ID: 12624744
[TBL] [Abstract][Full Text] [Related]
8. Down syndrome--a disruption of homeostasis.
Shapiro BL
Am J Med Genet; 1983 Feb; 14(2):241-69. PubMed ID: 6220605
[TBL] [Abstract][Full Text] [Related]
9. Using mouse models to explore genotype-phenotype relationship in Down syndrome.
Salehi A; Faizi M; Belichenko PV; Mobley WC
Ment Retard Dev Disabil Res Rev; 2007; 13(3):207-14. PubMed ID: 17910089
[TBL] [Abstract][Full Text] [Related]
10. Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice.
Olson LE; Roper RJ; Sengstaken CL; Peterson EA; Aquino V; Galdzicki Z; Siarey R; Pletnikov M; Moran TH; Reeves RH
Hum Mol Genet; 2007 Apr; 16(7):774-82. PubMed ID: 17339268
[TBL] [Abstract][Full Text] [Related]
11. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part II).
Cheon MS; Bajo M; Kim SH; Claudio JO; Stewart AK; Patterson D; Kruger WD; Kondoh H; Lubec G
Amino Acids; 2003; 24(1-2):119-25. PubMed ID: 12624743
[TBL] [Abstract][Full Text] [Related]
12. Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice.
Richtsmeier JT; Baxter LL; Reeves RH
Dev Dyn; 2000 Feb; 217(2):137-45. PubMed ID: 10706138
[TBL] [Abstract][Full Text] [Related]
13. Molecular aspects of Down syndrome.
Dutta S; Nandagopal K; Gangopadhyay PK; Mukhopadhyay K
Indian Pediatr; 2005 Apr; 42(4):339-44. PubMed ID: 15876595
[TBL] [Abstract][Full Text] [Related]
14. Down syndrome gene dosage imbalance on cerebellum development.
Moldrich RX; Dauphinot L; Laffaire J; Rossier J; Potier MC
Prog Neurobiol; 2007 Jun; 82(2):87-94. PubMed ID: 17408845
[TBL] [Abstract][Full Text] [Related]
15. Genetic mechanisms involved in the phenotype of Down syndrome.
Patterson D
Ment Retard Dev Disabil Res Rev; 2007; 13(3):199-206. PubMed ID: 17910086
[TBL] [Abstract][Full Text] [Related]
16. The brain in Down syndrome (TRISOMY 21).
Lubec G; Engidawork E
J Neurol; 2002 Oct; 249(10):1347-56. PubMed ID: 12382149
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional disruptions in Down syndrome: a case study in the Ts1Cje mouse cerebellum during post-natal development.
Potier MC; Rivals I; Mercier G; Ettwiller L; Moldrich RX; Laffaire J; Personnaz L; Rossier J; Dauphinot L
J Neurochem; 2006 Apr; 97 Suppl 1():104-9. PubMed ID: 16635258
[TBL] [Abstract][Full Text] [Related]
18. Chromosome 21 and down syndrome: from genomics to pathophysiology.
Antonarakis SE; Lyle R; Dermitzakis ET; Reymond A; Deutsch S
Nat Rev Genet; 2004 Oct; 5(10):725-38. PubMed ID: 15510164
[TBL] [Abstract][Full Text] [Related]
19. Cooperation to amplify gene-dosage-imbalance effects.
de la Luna S; Estivill X
Trends Mol Med; 2006 Oct; 12(10):451-4. PubMed ID: 16919501
[TBL] [Abstract][Full Text] [Related]
20. Protein expression of BACE1, BACE2 and APP in Down syndrome brains.
Cheon MS; Dierssen M; Kim SH; Lubec G
Amino Acids; 2008 Aug; 35(2):339-43. PubMed ID: 18163181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
